glp-1 and steroids A Closer Look at the Dermatological Profile of Agonists GLP-1 Agonists in Transplant Patients:
Description
The dual-receptor action of tirzepatide may produce more pronounced gastric effects in some individuals, which could translate to higher heartburn rates

Studies suggest muscle loss with these medications (as indicated by decreases in fat-free mass) ranges from 25% to 39% of the total weight lost over 3672 weeks [173,174]

It should document a BMI of 30 or higher (or 27-plus with a comorbidity like hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), failed diet and exercise, and cardiovascular or metabolic risk

Mental health is not a footnoteits central to success

doi: 10.1042/bj1250050p

Medical Disclaimer This article is for educational purposes only
